nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—PON1—type 2 diabetes mellitus	0.403	0.9	CbGaD
Cefazolin—ABCC4—Nateglinide—type 2 diabetes mellitus	0.0591	0.169	CbGbCtD
Cefazolin—ALB—type 2 diabetes mellitus	0.0449	0.1	CbGaD
Cefazolin—ALB—Gliclazide—type 2 diabetes mellitus	0.034	0.0975	CbGbCtD
Cefazolin—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0339	0.0973	CbGbCtD
Cefazolin—ALB—Repaglinide—type 2 diabetes mellitus	0.032	0.0916	CbGbCtD
Cefazolin—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0303	0.0867	CbGbCtD
Cefazolin—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0267	0.0765	CbGbCtD
Cefazolin—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0257	0.0737	CbGbCtD
Cefazolin—ALB—Valsartan—type 2 diabetes mellitus	0.0236	0.0676	CbGbCtD
Cefazolin—ALB—Nateglinide—type 2 diabetes mellitus	0.0219	0.0628	CbGbCtD
Cefazolin—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0174	0.0498	CbGbCtD
Cefazolin—SLC22A6—Losartan—type 2 diabetes mellitus	0.0159	0.0456	CbGbCtD
Cefazolin—ALB—Glyburide—type 2 diabetes mellitus	0.0148	0.0424	CbGbCtD
Cefazolin—ALB—Losartan—type 2 diabetes mellitus	0.0135	0.0388	CbGbCtD
Cefazolin—PON1—artery—type 2 diabetes mellitus	0.00817	0.276	CbGeAlD
Cefazolin—PON1—cardiovascular system—type 2 diabetes mellitus	0.00284	0.0958	CbGeAlD
Cefazolin—PON1—liver—type 2 diabetes mellitus	0.00176	0.0593	CbGeAlD
Cefazolin—TPMT—islet of Langerhans—type 2 diabetes mellitus	0.00119	0.0403	CbGeAlD
Cefazolin—TPMT—retina—type 2 diabetes mellitus	0.00102	0.0345	CbGeAlD
Cefazolin—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.00102	0.0343	CbGeAlD
Cefazolin—TPMT—nephron tubule—type 2 diabetes mellitus	0.000962	0.0325	CbGeAlD
Cefazolin—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000958	0.0323	CbGeAlD
Cefazolin—SLC22A11—kidney—type 2 diabetes mellitus	0.000893	0.0301	CbGeAlD
Cefazolin—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.00087	0.0294	CbGeAlD
Cefazolin—TPMT—kidney—type 2 diabetes mellitus	0.000845	0.0285	CbGeAlD
Cefazolin—TPMT—pancreas—type 2 diabetes mellitus	0.00084	0.0283	CbGeAlD
Cefazolin—TPMT—cortex of kidney—type 2 diabetes mellitus	0.000823	0.0278	CbGeAlD
Cefazolin—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00082	0.0277	CbGeAlD
Cefazolin—TPMT—adipose tissue—type 2 diabetes mellitus	0.000762	0.0257	CbGeAlD
Cefazolin—ABCC4—nephron tubule—type 2 diabetes mellitus	0.000578	0.0195	CbGeAlD
Cefazolin—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000573	0.0193	CbGeAlD
Cefazolin—SLC22A11—liver—type 2 diabetes mellitus	0.000565	0.0191	CbGeAlD
Cefazolin—TPMT—liver—type 2 diabetes mellitus	0.000534	0.018	CbGeAlD
Cefazolin—ABCC4—kidney—type 2 diabetes mellitus	0.000508	0.0171	CbGeAlD
Cefazolin—ABCC4—pancreas—type 2 diabetes mellitus	0.000505	0.017	CbGeAlD
Cefazolin—SLC22A8—kidney—type 2 diabetes mellitus	0.000504	0.017	CbGeAlD
Cefazolin—ABCC4—cortex of kidney—type 2 diabetes mellitus	0.000495	0.0167	CbGeAlD
Cefazolin—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000491	0.0166	CbGeAlD
Cefazolin—ABCC4—adipose tissue—type 2 diabetes mellitus	0.000458	0.0154	CbGeAlD
Cefazolin—ALB—liver—type 2 diabetes mellitus	0.000332	0.0112	CbGeAlD
Cefazolin—ABCC4—liver—type 2 diabetes mellitus	0.000321	0.0108	CbGeAlD
Cefazolin—Cefotetan—ALB—type 2 diabetes mellitus	0.000196	0.182	CrCbGaD
Cefazolin—Cefpiramide—ALB—type 2 diabetes mellitus	0.000171	0.159	CrCbGaD
Cefazolin—Cefonicid—ALB—type 2 diabetes mellitus	0.000149	0.138	CrCbGaD
Cefazolin—Cefmetazole—ALB—type 2 diabetes mellitus	0.000131	0.122	CrCbGaD
Cefazolin—Flatulence—Metformin—type 2 diabetes mellitus	0.000129	0.00108	CcSEcCtD
Cefazolin—Syncope—Valsartan—type 2 diabetes mellitus	0.000129	0.00108	CcSEcCtD
Cefazolin—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000129	0.00108	CcSEcCtD
Cefazolin—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000128	0.00107	CcSEcCtD
Cefazolin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000127	0.00107	CcSEcCtD
Cefazolin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000127	0.00107	CcSEcCtD
Cefazolin—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000127	0.00106	CcSEcCtD
Cefazolin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000126	0.00106	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000126	0.00106	CcSEcCtD
Cefazolin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000126	0.00106	CcSEcCtD
Cefazolin—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000126	0.00106	CcSEcCtD
Cefazolin—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000126	0.00106	CcSEcCtD
Cefazolin—Renal failure—Ramipril—type 2 diabetes mellitus	0.000125	0.00105	CcSEcCtD
Cefazolin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000125	0.00105	CcSEcCtD
Cefazolin—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000125	0.00105	CcSEcCtD
Cefazolin—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000125	0.00105	CcSEcCtD
Cefazolin—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000124	0.00104	CcSEcCtD
Cefazolin—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000124	0.00104	CcSEcCtD
Cefazolin—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000123	0.00104	CcSEcCtD
Cefazolin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000123	0.00104	CcSEcCtD
Cefazolin—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000123	0.00103	CcSEcCtD
Cefazolin—Convulsion—Orlistat—type 2 diabetes mellitus	0.000123	0.00103	CcSEcCtD
Cefazolin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000123	0.00103	CcSEcCtD
Cefazolin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000123	0.00103	CcSEcCtD
Cefazolin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000122	0.00102	CcSEcCtD
Cefazolin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000122	0.00102	CcSEcCtD
Cefazolin—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000122	0.00102	CcSEcCtD
Cefazolin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000121	0.00102	CcSEcCtD
Cefazolin—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000119	0.001	CcSEcCtD
Cefazolin—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000119	0.000998	CcSEcCtD
Cefazolin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000118	0.000989	CcSEcCtD
Cefazolin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000117	0.000986	CcSEcCtD
Cefazolin—Vomiting—Glipizide—type 2 diabetes mellitus	0.000117	0.000985	CcSEcCtD
Cefazolin—Syncope—Metformin—type 2 diabetes mellitus	0.000117	0.000984	CcSEcCtD
Cefazolin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000117	0.000984	CcSEcCtD
Cefazolin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000117	0.000982	CcSEcCtD
Cefazolin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000117	0.000981	CcSEcCtD
Cefazolin—Rash—Glipizide—type 2 diabetes mellitus	0.000116	0.000977	CcSEcCtD
Cefazolin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000116	0.000976	CcSEcCtD
Cefazolin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000116	0.000975	CcSEcCtD
Cefazolin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000116	0.000972	CcSEcCtD
Cefazolin—Headache—Glipizide—type 2 diabetes mellitus	0.000116	0.00097	CcSEcCtD
Cefazolin—Shock—Valsartan—type 2 diabetes mellitus	0.000115	0.000968	CcSEcCtD
Cefazolin—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000115	0.000965	CcSEcCtD
Cefazolin—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000115	0.000963	CcSEcCtD
Cefazolin—Flatulence—Losartan—type 2 diabetes mellitus	0.000114	0.00096	CcSEcCtD
Cefazolin—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000114	0.00096	CcSEcCtD
Cefazolin—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000114	0.000957	CcSEcCtD
Cefazolin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000114	0.000956	CcSEcCtD
Cefazolin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000114	0.000953	CcSEcCtD
Cefazolin—Agitation—Irbesartan—type 2 diabetes mellitus	0.000113	0.000952	CcSEcCtD
Cefazolin—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000113	0.000952	CcSEcCtD
Cefazolin—Urticaria—Glyburide—type 2 diabetes mellitus	0.000113	0.000947	CcSEcCtD
Cefazolin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000112	0.000942	CcSEcCtD
Cefazolin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000112	0.000942	CcSEcCtD
Cefazolin—Anorexia—Valsartan—type 2 diabetes mellitus	0.000112	0.000938	CcSEcCtD
Cefazolin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000936	CcSEcCtD
Cefazolin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000111	0.00093	CcSEcCtD
Cefazolin—Syncope—Irbesartan—type 2 diabetes mellitus	0.000111	0.000929	CcSEcCtD
Cefazolin—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000927	CcSEcCtD
Cefazolin—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00011	0.000923	CcSEcCtD
Cefazolin—Nausea—Glipizide—type 2 diabetes mellitus	0.00011	0.00092	CcSEcCtD
Cefazolin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000109	0.000919	CcSEcCtD
Cefazolin—Hypotension—Valsartan—type 2 diabetes mellitus	0.000109	0.000919	CcSEcCtD
Cefazolin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000109	0.000916	CcSEcCtD
Cefazolin—Pain—Gliclazide—type 2 diabetes mellitus	0.000109	0.000915	CcSEcCtD
Cefazolin—Rash—Glimepiride—type 2 diabetes mellitus	0.000109	0.000911	CcSEcCtD
Cefazolin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000108	0.000911	CcSEcCtD
Cefazolin—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000108	0.00091	CcSEcCtD
Cefazolin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000108	0.000909	CcSEcCtD
Cefazolin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000108	0.000908	CcSEcCtD
Cefazolin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000108	0.000908	CcSEcCtD
Cefazolin—Headache—Glimepiride—type 2 diabetes mellitus	0.000108	0.000906	CcSEcCtD
Cefazolin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000108	0.000903	CcSEcCtD
Cefazolin—Anaemia—Losartan—type 2 diabetes mellitus	0.000107	0.000901	CcSEcCtD
Cefazolin—Agitation—Losartan—type 2 diabetes mellitus	0.000107	0.000896	CcSEcCtD
Cefazolin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000892	CcSEcCtD
Cefazolin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000105	0.000882	CcSEcCtD
Cefazolin—Shock—Metformin—type 2 diabetes mellitus	0.000105	0.000881	CcSEcCtD
Cefazolin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000105	0.000878	CcSEcCtD
Cefazolin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000104	0.000877	CcSEcCtD
Cefazolin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000104	0.000875	CcSEcCtD
Cefazolin—Somnolence—Valsartan—type 2 diabetes mellitus	0.000104	0.000874	CcSEcCtD
Cefazolin—Syncope—Losartan—type 2 diabetes mellitus	0.000104	0.000874	CcSEcCtD
Cefazolin—Leukopenia—Losartan—type 2 diabetes mellitus	0.000104	0.000872	CcSEcCtD
Cefazolin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000103	0.000866	CcSEcCtD
Cefazolin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000862	CcSEcCtD
Cefazolin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000102	0.000859	CcSEcCtD
Cefazolin—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000102	0.000857	CcSEcCtD
Cefazolin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000102	0.000856	CcSEcCtD
Cefazolin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000102	0.000855	CcSEcCtD
Cefazolin—Asthenia—Glyburide—type 2 diabetes mellitus	0.000102	0.000855	CcSEcCtD
Cefazolin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000102	0.000855	CcSEcCtD
Cefazolin—Anorexia—Metformin—type 2 diabetes mellitus	0.000102	0.000854	CcSEcCtD
Cefazolin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000101	0.00085	CcSEcCtD
Cefazolin—Fatigue—Valsartan—type 2 diabetes mellitus	0.000101	0.000848	CcSEcCtD
Cefazolin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000101	0.000846	CcSEcCtD
Cefazolin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000101	0.000846	CcSEcCtD
Cefazolin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000101	0.000845	CcSEcCtD
Cefazolin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000101	0.000845	CcSEcCtD
Cefazolin—Pruritus—Glyburide—type 2 diabetes mellitus	0.0001	0.000843	CcSEcCtD
Cefazolin—Fatigue—Orlistat—type 2 diabetes mellitus	9.98e-05	0.000838	CcSEcCtD
Cefazolin—Hypotension—Metformin—type 2 diabetes mellitus	9.97e-05	0.000837	CcSEcCtD
Cefazolin—Shock—Irbesartan—type 2 diabetes mellitus	9.91e-05	0.000832	CcSEcCtD
Cefazolin—Pain—Orlistat—type 2 diabetes mellitus	9.9e-05	0.000831	CcSEcCtD
Cefazolin—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.88e-05	0.000829	CcSEcCtD
Cefazolin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.86e-05	0.000828	CcSEcCtD
Cefazolin—Rash—Bromocriptine—type 2 diabetes mellitus	9.79e-05	0.000822	CcSEcCtD
Cefazolin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.79e-05	0.000822	CcSEcCtD
Cefazolin—Headache—Bromocriptine—type 2 diabetes mellitus	9.73e-05	0.000817	CcSEcCtD
Cefazolin—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.72e-05	0.000816	CcSEcCtD
Cefazolin—Cefradine—CYP3A4—type 2 diabetes mellitus	9.63e-05	0.0896	CrCbGaD
Cefazolin—Anorexia—Irbesartan—type 2 diabetes mellitus	9.6e-05	0.000806	CcSEcCtD
Cefazolin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.58e-05	0.000804	CcSEcCtD
Cefazolin—Confusional state—Losartan—type 2 diabetes mellitus	9.55e-05	0.000802	CcSEcCtD
Cefazolin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.54e-05	0.000801	CcSEcCtD
Cefazolin—Somnolence—Metformin—type 2 diabetes mellitus	9.48e-05	0.000796	CcSEcCtD
Cefazolin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.47e-05	0.000795	CcSEcCtD
Cefazolin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.47e-05	0.000795	CcSEcCtD
Cefazolin—Hypotension—Irbesartan—type 2 diabetes mellitus	9.41e-05	0.00079	CcSEcCtD
Cefazolin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.39e-05	0.000789	CcSEcCtD
Cefazolin—Dyspepsia—Metformin—type 2 diabetes mellitus	9.39e-05	0.000788	CcSEcCtD
Cefazolin—Shock—Losartan—type 2 diabetes mellitus	9.32e-05	0.000783	CcSEcCtD
Cefazolin—Urticaria—Valsartan—type 2 diabetes mellitus	9.31e-05	0.000781	CcSEcCtD
Cefazolin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.28e-05	0.000779	CcSEcCtD
Cefazolin—Decreased appetite—Metformin—type 2 diabetes mellitus	9.27e-05	0.000779	CcSEcCtD
Cefazolin—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.26e-05	0.000778	CcSEcCtD
Cefazolin—Nausea—Bromocriptine—type 2 diabetes mellitus	9.23e-05	0.000775	CcSEcCtD
Cefazolin—Fatigue—Metformin—type 2 diabetes mellitus	9.2e-05	0.000772	CcSEcCtD
Cefazolin—Urticaria—Orlistat—type 2 diabetes mellitus	9.2e-05	0.000772	CcSEcCtD
Cefazolin—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.15e-05	0.000768	CcSEcCtD
Cefazolin—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.15e-05	0.000768	CcSEcCtD
Cefazolin—Asthenia—Gliclazide—type 2 diabetes mellitus	9.15e-05	0.000768	CcSEcCtD
Cefazolin—Agitation—Ramipril—type 2 diabetes mellitus	9.15e-05	0.000768	CcSEcCtD
Cefazolin—Anorexia—Losartan—type 2 diabetes mellitus	9.03e-05	0.000758	CcSEcCtD
Cefazolin—Vomiting—Glyburide—type 2 diabetes mellitus	9.03e-05	0.000758	CcSEcCtD
Cefazolin—Pruritus—Gliclazide—type 2 diabetes mellitus	9.02e-05	0.000757	CcSEcCtD
Cefazolin—Rash—Glyburide—type 2 diabetes mellitus	8.95e-05	0.000752	CcSEcCtD
Cefazolin—Somnolence—Irbesartan—type 2 diabetes mellitus	8.95e-05	0.000751	CcSEcCtD
Cefazolin—Dermatitis—Glyburide—type 2 diabetes mellitus	8.95e-05	0.000751	CcSEcCtD
Cefazolin—Syncope—Ramipril—type 2 diabetes mellitus	8.93e-05	0.000749	CcSEcCtD
Cefazolin—Leukopenia—Ramipril—type 2 diabetes mellitus	8.91e-05	0.000748	CcSEcCtD
Cefazolin—Headache—Glyburide—type 2 diabetes mellitus	8.9e-05	0.000747	CcSEcCtD
Cefazolin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.000744	CcSEcCtD
Cefazolin—Hypotension—Losartan—type 2 diabetes mellitus	8.85e-05	0.000743	CcSEcCtD
Cefazolin—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.79e-05	0.000738	CcSEcCtD
Cefazolin—Cefoperazone—ALB—type 2 diabetes mellitus	8.76e-05	0.0815	CrCbGaD
Cefazolin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000735	CcSEcCtD
Cefazolin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.75e-05	0.000735	CcSEcCtD
Cefazolin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.72e-05	0.000732	CcSEcCtD
Cefazolin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.72e-05	0.000732	CcSEcCtD
Cefazolin—Fatigue—Irbesartan—type 2 diabetes mellitus	8.68e-05	0.000729	CcSEcCtD
Cefazolin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.63e-05	0.000725	CcSEcCtD
Cefazolin—Convulsion—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000724	CcSEcCtD
Cefazolin—Pain—Irbesartan—type 2 diabetes mellitus	8.61e-05	0.000723	CcSEcCtD
Cefazolin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.53e-05	0.000716	CcSEcCtD
Cefazolin—Urticaria—Metformin—type 2 diabetes mellitus	8.48e-05	0.000712	CcSEcCtD
Cefazolin—Nausea—Glyburide—type 2 diabetes mellitus	8.43e-05	0.000708	CcSEcCtD
Cefazolin—Abdominal pain—Metformin—type 2 diabetes mellitus	8.43e-05	0.000708	CcSEcCtD
Cefazolin—Dizziness—Gliclazide—type 2 diabetes mellitus	8.43e-05	0.000708	CcSEcCtD
Cefazolin—Somnolence—Losartan—type 2 diabetes mellitus	8.42e-05	0.000707	CcSEcCtD
Cefazolin—Asthenia—Valsartan—type 2 diabetes mellitus	8.41e-05	0.000706	CcSEcCtD
Cefazolin—Dyspepsia—Losartan—type 2 diabetes mellitus	8.34e-05	0.0007	CcSEcCtD
Cefazolin—Asthenia—Orlistat—type 2 diabetes mellitus	8.31e-05	0.000697	CcSEcCtD
Cefazolin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.3e-05	0.000697	CcSEcCtD
Cefazolin—Pruritus—Valsartan—type 2 diabetes mellitus	8.29e-05	0.000696	CcSEcCtD
Cefazolin—Decreased appetite—Losartan—type 2 diabetes mellitus	8.24e-05	0.000691	CcSEcCtD
Cefazolin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.23e-05	0.000691	CcSEcCtD
Cefazolin—Confusional state—Ramipril—type 2 diabetes mellitus	8.19e-05	0.000688	CcSEcCtD
Cefazolin—Pruritus—Orlistat—type 2 diabetes mellitus	8.19e-05	0.000688	CcSEcCtD
Cefazolin—Fatigue—Losartan—type 2 diabetes mellitus	8.17e-05	0.000686	CcSEcCtD
Cefazolin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000682	CcSEcCtD
Cefazolin—Vomiting—Gliclazide—type 2 diabetes mellitus	8.11e-05	0.000681	CcSEcCtD
Cefazolin—Pain—Losartan—type 2 diabetes mellitus	8.1e-05	0.00068	CcSEcCtD
Cefazolin—Rash—Gliclazide—type 2 diabetes mellitus	8.04e-05	0.000675	CcSEcCtD
Cefazolin—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.03e-05	0.000674	CcSEcCtD
Cefazolin—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.02e-05	0.000673	CcSEcCtD
Cefazolin—Urticaria—Irbesartan—type 2 diabetes mellitus	8e-05	0.000671	CcSEcCtD
Cefazolin—Shock—Ramipril—type 2 diabetes mellitus	7.99e-05	0.000671	CcSEcCtD
Cefazolin—Headache—Gliclazide—type 2 diabetes mellitus	7.99e-05	0.000671	CcSEcCtD
Cefazolin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.96e-05	0.000668	CcSEcCtD
Cefazolin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.96e-05	0.000668	CcSEcCtD
Cefazolin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.95e-05	0.000668	CcSEcCtD
Cefazolin—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.92e-05	0.000665	CcSEcCtD
Cefazolin—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.81e-05	0.000655	CcSEcCtD
Cefazolin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.75e-05	0.00065	CcSEcCtD
Cefazolin—Dizziness—Valsartan—type 2 diabetes mellitus	7.75e-05	0.00065	CcSEcCtD
Cefazolin—Anorexia—Ramipril—type 2 diabetes mellitus	7.74e-05	0.00065	CcSEcCtD
Cefazolin—Dizziness—Orlistat—type 2 diabetes mellitus	7.66e-05	0.000643	CcSEcCtD
Cefazolin—Asthenia—Metformin—type 2 diabetes mellitus	7.65e-05	0.000643	CcSEcCtD
Cefazolin—Hypotension—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000637	CcSEcCtD
Cefazolin—Nausea—Gliclazide—type 2 diabetes mellitus	7.57e-05	0.000636	CcSEcCtD
Cefazolin—Pruritus—Metformin—type 2 diabetes mellitus	7.55e-05	0.000634	CcSEcCtD
Cefazolin—Urticaria—Losartan—type 2 diabetes mellitus	7.53e-05	0.000632	CcSEcCtD
Cefazolin—Abdominal pain—Losartan—type 2 diabetes mellitus	7.49e-05	0.000629	CcSEcCtD
Cefazolin—Body temperature increased—Losartan—type 2 diabetes mellitus	7.49e-05	0.000629	CcSEcCtD
Cefazolin—Vomiting—Valsartan—type 2 diabetes mellitus	7.45e-05	0.000625	CcSEcCtD
Cefazolin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.000623	CcSEcCtD
Cefazolin—Rash—Valsartan—type 2 diabetes mellitus	7.39e-05	0.00062	CcSEcCtD
Cefazolin—Dermatitis—Valsartan—type 2 diabetes mellitus	7.38e-05	0.00062	CcSEcCtD
Cefazolin—Vomiting—Orlistat—type 2 diabetes mellitus	7.36e-05	0.000618	CcSEcCtD
Cefazolin—Headache—Valsartan—type 2 diabetes mellitus	7.34e-05	0.000616	CcSEcCtD
Cefazolin—Diarrhoea—Metformin—type 2 diabetes mellitus	7.3e-05	0.000613	CcSEcCtD
Cefazolin—Rash—Orlistat—type 2 diabetes mellitus	7.3e-05	0.000613	CcSEcCtD
Cefazolin—Dermatitis—Orlistat—type 2 diabetes mellitus	7.29e-05	0.000612	CcSEcCtD
Cefazolin—Headache—Orlistat—type 2 diabetes mellitus	7.25e-05	0.000609	CcSEcCtD
Cefazolin—Asthenia—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000606	CcSEcCtD
Cefazolin—Somnolence—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000606	CcSEcCtD
Cefazolin—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.15e-05	0.0006	CcSEcCtD
Cefazolin—Pruritus—Irbesartan—type 2 diabetes mellitus	7.12e-05	0.000598	CcSEcCtD
Cefazolin—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000593	CcSEcCtD
Cefazolin—Dizziness—Metformin—type 2 diabetes mellitus	7.05e-05	0.000592	CcSEcCtD
Cefazolin—Fatigue—Ramipril—type 2 diabetes mellitus	7e-05	0.000588	CcSEcCtD
Cefazolin—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.98e-05	0.000586	CcSEcCtD
Cefazolin—Nausea—Valsartan—type 2 diabetes mellitus	6.96e-05	0.000584	CcSEcCtD
Cefazolin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.000578	CcSEcCtD
Cefazolin—Nausea—Orlistat—type 2 diabetes mellitus	6.88e-05	0.000577	CcSEcCtD
Cefazolin—Ceftriaxone—ALB—type 2 diabetes mellitus	6.83e-05	0.0635	CrCbGaD
Cefazolin—Asthenia—Losartan—type 2 diabetes mellitus	6.8e-05	0.000571	CcSEcCtD
Cefazolin—Vomiting—Metformin—type 2 diabetes mellitus	6.78e-05	0.000569	CcSEcCtD
Cefazolin—Rash—Metformin—type 2 diabetes mellitus	6.73e-05	0.000565	CcSEcCtD
Cefazolin—Dermatitis—Metformin—type 2 diabetes mellitus	6.72e-05	0.000564	CcSEcCtD
Cefazolin—Pruritus—Losartan—type 2 diabetes mellitus	6.7e-05	0.000563	CcSEcCtD
Cefazolin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000562	CcSEcCtD
Cefazolin—Headache—Metformin—type 2 diabetes mellitus	6.68e-05	0.000561	CcSEcCtD
Cefazolin—Dizziness—Irbesartan—type 2 diabetes mellitus	6.66e-05	0.000559	CcSEcCtD
Cefazolin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000558	CcSEcCtD
Cefazolin—Diarrhoea—Losartan—type 2 diabetes mellitus	6.48e-05	0.000544	CcSEcCtD
Cefazolin—Urticaria—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000542	CcSEcCtD
Cefazolin—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000539	CcSEcCtD
Cefazolin—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000539	CcSEcCtD
Cefazolin—Vomiting—Irbesartan—type 2 diabetes mellitus	6.4e-05	0.000537	CcSEcCtD
Cefazolin—Rash—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.000533	CcSEcCtD
Cefazolin—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.34e-05	0.000532	CcSEcCtD
Cefazolin—Nausea—Metformin—type 2 diabetes mellitus	6.34e-05	0.000532	CcSEcCtD
Cefazolin—Headache—Irbesartan—type 2 diabetes mellitus	6.31e-05	0.00053	CcSEcCtD
Cefazolin—Dizziness—Losartan—type 2 diabetes mellitus	6.27e-05	0.000526	CcSEcCtD
Cefazolin—Cephalexin—CYP3A4—type 2 diabetes mellitus	6.23e-05	0.0579	CrCbGaD
Cefazolin—Vomiting—Losartan—type 2 diabetes mellitus	6.02e-05	0.000506	CcSEcCtD
Cefazolin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000503	CcSEcCtD
Cefazolin—Nausea—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000502	CcSEcCtD
Cefazolin—Cefalotin—ALB—type 2 diabetes mellitus	5.98e-05	0.0556	CrCbGaD
Cefazolin—Rash—Losartan—type 2 diabetes mellitus	5.97e-05	0.000502	CcSEcCtD
Cefazolin—Dermatitis—Losartan—type 2 diabetes mellitus	5.97e-05	0.000501	CcSEcCtD
Cefazolin—Headache—Losartan—type 2 diabetes mellitus	5.94e-05	0.000498	CcSEcCtD
Cefazolin—Asthenia—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000489	CcSEcCtD
Cefazolin—Pruritus—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000483	CcSEcCtD
Cefazolin—Nausea—Losartan—type 2 diabetes mellitus	5.63e-05	0.000472	CcSEcCtD
Cefazolin—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000467	CcSEcCtD
Cefazolin—Cephalexin—ALB—type 2 diabetes mellitus	5.43e-05	0.0506	CrCbGaD
Cefazolin—Dizziness—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000451	CcSEcCtD
Cefazolin—Vomiting—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000434	CcSEcCtD
Cefazolin—Rash—Ramipril—type 2 diabetes mellitus	5.12e-05	0.00043	CcSEcCtD
Cefazolin—Dermatitis—Ramipril—type 2 diabetes mellitus	5.12e-05	0.00043	CcSEcCtD
Cefazolin—Headache—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000427	CcSEcCtD
Cefazolin—Nausea—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000405	CcSEcCtD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SOD1—type 2 diabetes mellitus	2.14e-05	0.0004	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.13e-05	0.000398	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.12e-05	0.000396	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ADCY5—type 2 diabetes mellitus	2.12e-05	0.000396	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.12e-05	0.000395	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.12e-05	0.000395	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GPX1—type 2 diabetes mellitus	2.11e-05	0.000394	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.11e-05	0.000394	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.11e-05	0.000394	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.1e-05	0.000393	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.09e-05	0.000391	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.08e-05	0.000388	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—GNB3—type 2 diabetes mellitus	2.07e-05	0.000387	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.06e-05	0.000385	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CD36—type 2 diabetes mellitus	2.06e-05	0.000384	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.04e-05	0.000382	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CD36—type 2 diabetes mellitus	2.04e-05	0.000381	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IGF2—type 2 diabetes mellitus	2.04e-05	0.00038	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.03e-05	0.00038	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.03e-05	0.00038	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPP2CA—type 2 diabetes mellitus	2.03e-05	0.000379	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PPP2CA—type 2 diabetes mellitus	2.02e-05	0.000377	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.02e-05	0.000376	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	1.98e-05	0.00037	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	1.97e-05	0.000367	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MTHFR—type 2 diabetes mellitus	1.95e-05	0.000364	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.95e-05	0.000364	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	1.94e-05	0.000362	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—VEGFA—type 2 diabetes mellitus	1.93e-05	0.000359	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TNF—type 2 diabetes mellitus	1.92e-05	0.000359	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.92e-05	0.000359	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPARA—type 2 diabetes mellitus	1.91e-05	0.000357	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	1.91e-05	0.000356	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.9e-05	0.000355	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	1.89e-05	0.000352	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—THBD—type 2 diabetes mellitus	1.89e-05	0.000352	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MMP1—type 2 diabetes mellitus	1.86e-05	0.000348	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AGT—type 2 diabetes mellitus	1.85e-05	0.000346	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—type 2 diabetes mellitus	1.83e-05	0.000342	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	1.83e-05	0.000341	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	1.83e-05	0.000341	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.82e-05	0.00034	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CALM1—type 2 diabetes mellitus	1.82e-05	0.00034	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—APOE—type 2 diabetes mellitus	1.81e-05	0.000339	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CALM1—type 2 diabetes mellitus	1.81e-05	0.000338	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.8e-05	0.000336	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.8e-05	0.000335	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—APOA1—type 2 diabetes mellitus	1.79e-05	0.000335	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—CD36—type 2 diabetes mellitus	1.79e-05	0.000335	CbGpPWpGaD
Cefazolin—ALB—Metabolism—BHMT—type 2 diabetes mellitus	1.79e-05	0.000335	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—APOA1—type 2 diabetes mellitus	1.78e-05	0.000333	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.78e-05	0.000332	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.77e-05	0.000331	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—TGFB1—type 2 diabetes mellitus	1.77e-05	0.00033	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.76e-05	0.000328	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.74e-05	0.000324	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	1.73e-05	0.000323	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.71e-05	0.00032	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PRKCB—type 2 diabetes mellitus	1.7e-05	0.000317	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.7e-05	0.000317	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—type 2 diabetes mellitus	1.68e-05	0.000314	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS2—type 2 diabetes mellitus	1.68e-05	0.000314	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.67e-05	0.000312	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.67e-05	0.000311	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.64e-05	0.000307	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.61e-05	0.0003	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ATP2A2—type 2 diabetes mellitus	1.59e-05	0.000298	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—CALM1—type 2 diabetes mellitus	1.59e-05	0.000296	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.59e-05	0.000296	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPARG—type 2 diabetes mellitus	1.58e-05	0.000295	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGDS—type 2 diabetes mellitus	1.57e-05	0.000292	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AANAT—type 2 diabetes mellitus	1.57e-05	0.000292	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—APOA1—type 2 diabetes mellitus	1.56e-05	0.000292	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—type 2 diabetes mellitus	1.55e-05	0.00029	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—INS—type 2 diabetes mellitus	1.55e-05	0.000289	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TRPC6—type 2 diabetes mellitus	1.55e-05	0.000289	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.54e-05	0.000288	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	1.53e-05	0.000285	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—F7—type 2 diabetes mellitus	1.52e-05	0.000284	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	1.49e-05	0.000279	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.49e-05	0.000278	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IGF1—type 2 diabetes mellitus	1.49e-05	0.000278	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT2—type 2 diabetes mellitus	1.49e-05	0.000278	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CDO1—type 2 diabetes mellitus	1.48e-05	0.000277	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPD2—type 2 diabetes mellitus	1.48e-05	0.000277	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.45e-05	0.000271	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.45e-05	0.00027	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.44e-05	0.000269	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.43e-05	0.000267	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALB—type 2 diabetes mellitus	1.42e-05	0.000265	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AK1—type 2 diabetes mellitus	1.42e-05	0.000264	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINE1—type 2 diabetes mellitus	1.41e-05	0.000264	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ALB—type 2 diabetes mellitus	1.41e-05	0.000263	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.4e-05	0.000261	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.38e-05	0.000258	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.38e-05	0.000258	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	1.36e-05	0.000254	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NOS3—type 2 diabetes mellitus	1.36e-05	0.000254	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3R1—type 2 diabetes mellitus	1.36e-05	0.000254	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	1.36e-05	0.000253	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	1.36e-05	0.000253	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS3—type 2 diabetes mellitus	1.35e-05	0.000252	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.35e-05	0.000252	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.35e-05	0.000251	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.34e-05	0.000251	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.34e-05	0.00025	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.33e-05	0.000249	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	1.31e-05	0.000244	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	1.31e-05	0.000244	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	1.31e-05	0.000244	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	1.31e-05	0.000244	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.3e-05	0.000243	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.28e-05	0.000239	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	1.27e-05	0.000238	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.27e-05	0.000238	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.27e-05	0.000236	CbGpPWpGaD
Cefazolin—ALB—Metabolism—G6PC—type 2 diabetes mellitus	1.26e-05	0.000236	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	1.26e-05	0.000236	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.26e-05	0.000236	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ND1—type 2 diabetes mellitus	1.26e-05	0.000236	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HBA2—type 2 diabetes mellitus	1.26e-05	0.000236	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS2—type 2 diabetes mellitus	1.24e-05	0.000232	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	1.24e-05	0.000232	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	1.24e-05	0.000231	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	1.23e-05	0.00023	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GCGR—type 2 diabetes mellitus	1.22e-05	0.000228	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.22e-05	0.000228	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	1.22e-05	0.000228	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.2e-05	0.000225	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	1.19e-05	0.000221	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.18e-05	0.00022	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.17e-05	0.000219	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYTB—type 2 diabetes mellitus	1.15e-05	0.000216	CbGpPWpGaD
Cefazolin—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	1.15e-05	0.000216	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	1.13e-05	0.00021	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.12e-05	0.000209	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	1.11e-05	0.000206	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	1.07e-05	0.0002	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACACA—type 2 diabetes mellitus	1.07e-05	0.0002	CbGpPWpGaD
Cefazolin—ALB—Metabolism—STAR—type 2 diabetes mellitus	1.07e-05	0.0002	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.07e-05	0.0002	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	1.07e-05	0.000199	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.06e-05	0.000199	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	1.05e-05	0.000196	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	1.03e-05	0.000192	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CBS—type 2 diabetes mellitus	1.03e-05	0.000192	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—APOB—type 2 diabetes mellitus	1.02e-05	0.00019	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SRC—type 2 diabetes mellitus	9.99e-06	0.000186	CbGpPWpGaD
Cefazolin—ALB—Metabolism—COX2—type 2 diabetes mellitus	9.91e-06	0.000185	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	9.91e-06	0.000185	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	9.73e-06	0.000182	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	9.73e-06	0.000182	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—type 2 diabetes mellitus	9.73e-06	0.000182	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	9.57e-06	0.000179	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UCP3—type 2 diabetes mellitus	9.57e-06	0.000179	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UCP2—type 2 diabetes mellitus	9.57e-06	0.000179	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	9.28e-06	0.000173	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.25e-06	0.000173	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CD36—type 2 diabetes mellitus	9.24e-06	0.000173	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.21e-06	0.000172	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	9.13e-06	0.00017	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.13e-06	0.00017	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PCK1—type 2 diabetes mellitus	9e-06	0.000168	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TGFB1—type 2 diabetes mellitus	8.93e-06	0.000167	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	8.86e-06	0.000165	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.82e-06	0.000165	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	8.77e-06	0.000164	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.64e-06	0.000161	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	8.54e-06	0.000159	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	8.43e-06	0.000157	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HK1—type 2 diabetes mellitus	8.42e-06	0.000157	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.42e-06	0.000157	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.24e-06	0.000154	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	8.18e-06	0.000153	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GCKR—type 2 diabetes mellitus	8.14e-06	0.000152	CbGpPWpGaD
Cefazolin—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	8.14e-06	0.000152	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	8.14e-06	0.000152	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LPA—type 2 diabetes mellitus	8.14e-06	0.000152	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	8.06e-06	0.00015	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	7.84e-06	0.000146	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.82e-06	0.000146	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	7.8e-06	0.000146	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	7.69e-06	0.000144	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	7.6e-06	0.000142	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.58e-06	0.000141	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.44e-06	0.000139	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.42e-06	0.000139	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.34e-06	0.000137	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	7.25e-06	0.000135	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.98e-06	0.00013	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	6.77e-06	0.000126	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	6.74e-06	0.000126	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	6.73e-06	0.000126	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTR—type 2 diabetes mellitus	6.63e-06	0.000124	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	6.63e-06	0.000124	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	6.5e-06	0.000121	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.47e-06	0.000121	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HBA1—type 2 diabetes mellitus	6.46e-06	0.000121	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LIPC—type 2 diabetes mellitus	6.46e-06	0.000121	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GCK—type 2 diabetes mellitus	6.46e-06	0.000121	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	6.42e-06	0.00012	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	6.4e-06	0.000119	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	6.31e-06	0.000118	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKT1—type 2 diabetes mellitus	6.25e-06	0.000117	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CETP—type 2 diabetes mellitus	6.24e-06	0.000116	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT1—type 2 diabetes mellitus	6.21e-06	0.000116	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	6.11e-06	0.000114	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	6.11e-06	0.000114	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	5.8e-06	0.000108	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	5.8e-06	0.000108	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	5.8e-06	0.000108	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CTGF—type 2 diabetes mellitus	5.69e-06	0.000106	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	5.64e-06	0.000105	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.56e-06	0.000104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	5.52e-06	0.000103	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.45e-06	0.000102	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	5.3e-06	9.9e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	5.24e-06	9.79e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	5.24e-06	9.79e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	5.11e-06	9.55e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.09e-06	9.5e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	5.03e-06	9.38e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GCG—type 2 diabetes mellitus	5.03e-06	9.38e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.52e-06	8.44e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	4.4e-06	8.22e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GNB3—type 2 diabetes mellitus	4.33e-06	8.09e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.33e-06	8.09e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4.31e-06	8.05e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CAT—type 2 diabetes mellitus	4.26e-06	7.94e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOB—type 2 diabetes mellitus	4.13e-06	7.71e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	4.04e-06	7.54e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	4.02e-06	7.5e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LPL—type 2 diabetes mellitus	3.94e-06	7.36e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.86e-06	7.21e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.85e-06	7.18e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.75e-06	7e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.7e-06	6.91e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.55e-06	6.63e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.48e-06	6.5e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.37e-06	6.3e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.32e-06	6.19e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.31e-06	6.17e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.27e-06	6.1e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.88e-06	5.38e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—INS—type 2 diabetes mellitus	2.82e-06	5.27e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.81e-06	5.24e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.48e-06	4.62e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.48e-06	4.62e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.27e-06	4.23e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.14e-06	2.13e-05	CbGpPWpGaD
